Hormone replacement therapy in the menopause: a suitable animal model.
Female CBA mice, aged 11 months, were treated cyclically with oral ethynyl oestradiol or oestrone sulphate for 3 months. The ovaries of all animals appeared to be atrophied. Target tissues throughout the genital tract showed a response to both oestrogens. Electron microscopy of both the endometrium and the urothelium demonstrated morphological changes characteristic of increased cellular metabolic activity in the treated mice. Endometrial hyperplasia developed in both treatment groups but more pronounced epithelial changes occurred with oestrone sulphate. This hyperplasia was accompanied by a doubling in the number of uterine cytoplasmic oestrogen receptors. A 50% fall in serum levels of luteinizing hormone in the treated mice revealed that the hypothalamic-pituitary system was still intact. Both oestrogens improved skeletal balance by changes in cortical-endosteal bone remodelling. The results suggest that the CBA strain of mouse is a suitable model for the study of the human climacteric and its response to hormone replacement therapy.
D000818:Animals; D003600:Cytosol / Q000378:metabolism; D004717:Endometrium / Q000187:drug effects / Q000648:ultrastructure; D004970:Estrone / Q000627:therapeutic use*; D004997:Ethinyl Estradiol / Q000627:therapeutic use*; D005260:Female; D005269:Femur / Q000187:drug effects; D005836:Genitalia, Female / Q000187:drug effects; D007986:Luteinizing Hormone / Q000097:blood; D008593:Menopause / Q000187:drug effects*; D051379:Mice; D008808:Mice, Inbred CBA; D008854:Microscopy, Electron; D008954:Models, Biological; D011960:Receptors, Estrogen / Q000378:metabolism; D001743:Urinary Bladder / Q000187:drug effects; D014599:Uterus / Q000187:drug effects / Q000378:metabolism
D011960:Receptors, Estrogen; D004970:Estrone; D004997:Ethinyl Estradiol; D007986:Luteinizing Hormone